Our research group used quantitative proteomics to investigate the differences in Aβ plaques in the AD human brain, the aging human brain and the APP/PS1 mouse brain and reported that synaptic structural proteins and complement proteins are upregulated in the Aβ plaques of the AD human brain [13]. This evidence concerns the gene APP and Alzheimer disease.